MedPath
HSA Approval

UROSIN FILM COATED TABLET 50 mg

SIN12330P

UROSIN FILM COATED TABLET 50 mg

UROSIN FILM COATED TABLET 50 mg

June 23, 2003

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

TABLET, FILM COATED

**Dosage and Administration:** Adults: 1. Hypertension: 50–100mg per day alone or in conjunction with other antihypertensive agents. The full effects of this dosage will usually be seen within 1–2 weeks. Increasing the dosage more than 100mg is unlikely to produce more beneficial effects. 2. Angina pectoris: The dosage for most patients is 50–100mg once a day or in divided doses. Increasing the dosage more than 100mg is unlikely to produce more beneficial effects. To be dispensed on physician's prescription.

ORAL

Medical Information

**Indication(s):** Hypertension, angina pectoris.

**Contraindication(s):** Contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. It should not be used in patients with asthma or a history of obstructive airway diseases.

C07AB03

atenolol

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

ATENOLOL

50 mg

Atenolol

Documents

Package Inserts

UROSIN FILM COATED TABLET 50MG_CLEAN_PI.pdf

Approved: July 13, 2022

Download
© Copyright 2025. All Rights Reserved by MedPath